logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
Ceased 2
  • 1
    Morgan, Alan Stuart
    President born in October 1964
    Individual (2 offsprings)
    Officer
    icon of calendar 2021-07-08 ~ 2023-03-06
    OF - Director → CIF 0
  • 2
    Paqueville, Frederic
    Managing Director born in April 1986
    Individual
    Officer
    icon of calendar 2023-03-06 ~ 2025-09-16
    OF - Director → CIF 0
parent relation
Company in focus

EXCELYA CLINICAL RESEARCH LIMITED

Standard Industrial Classification
78300 - Human Resources Provision And Management Of Human Resources Functions
86900 - Other Human Health Activities
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
72110 - Research And Experimental Development On Biotechnology
Brief company account
Debtors
-29,030 GBP2024-12-31
105,304 GBP2023-12-31
Cash at bank and in hand
54,976 GBP2024-12-31
Current Assets
25,946 GBP2024-12-31
105,304 GBP2023-12-31
Creditors
-938,886 GBP2024-12-31
-1,008,836 GBP2023-12-31
Net Current Assets/Liabilities
-912,940 GBP2024-12-31
-903,532 GBP2023-12-31
Total Assets Less Current Liabilities
-912,940 GBP2024-12-31
-903,532 GBP2023-12-31
Net Assets/Liabilities
-912,940 GBP2024-12-31
-903,532 GBP2023-12-31
Equity
Called up share capital
100 GBP2024-12-31
100 GBP2023-12-31
Retained earnings (accumulated losses)
-913,040 GBP2024-12-31
-903,632 GBP2023-12-31
Average Number of Employees
32024-01-01 ~ 2024-12-31
22023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Computers
843 GBP2024-12-31
843 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Computers
843 GBP2024-12-31
843 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
-39,989 GBP2024-12-31
90,198 GBP2023-12-31
Other Debtors
Current
8,166 GBP2024-12-31
8,166 GBP2023-12-31
Amount of value-added tax that is recoverable
Current
2,793 GBP2024-12-31
6,940 GBP2023-12-31
Trade Creditors/Trade Payables
Current
162,398 GBP2024-12-31
151,010 GBP2023-12-31
Bank Borrowings/Overdrafts
Current
101,246 GBP2023-12-31
Other Taxation & Social Security Payable
Current
180 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
1,200 GBP2024-12-31
1,200 GBP2023-12-31
Creditors
Current
938,886 GBP2024-12-31
1,008,836 GBP2023-12-31

  • EXCELYA CLINICAL RESEARCH LIMITED
    Info
    Registered number 13500517
    icon of address20-22 Venture West Greenham Business Park, Newbury RG19 6HX
    PRIVATE LIMITED COMPANY incorporated on 2021-07-08 (4 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-10-27
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 12 November 2025 and licensed under the Open Government Licence v3.0.